Waypoint Wealth Counsel Mustang Bio, Inc. Transaction History

Waypoint Wealth Counsel

  • $149 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 04, 2024
BUY
$0.35 - $0.72 $8,445 - $17,373
24,130 New
24,130 $8.85 Million
Q4 2022

Mar 22, 2024
BUY
$0.32 - $8.27 $8,841 - $228,500
27,630 New
27,630 $10.9 Million

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $22.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Waypoint Wealth Counsel Portfolio

Follow Waypoint Wealth Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Wealth Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Wealth Counsel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email